India Globalization Capital, Inc. (IGC) Short Interest Down 54.5% in September
India Globalization Capital, Inc. (NYSEAMERICAN:IGC) was the target of a significant drop in short interest in September. As of September 14th, there was short interest totalling 1,635,947 shares, a drop of 54.5% from the August 31st total of 3,593,660 shares. Approximately 6.3% of the company’s stock are sold short. Based on an average daily volume of 4,034,014 shares, the short-interest ratio is currently 0.4 days.
NYSEAMERICAN:IGC opened at $4.60 on Friday. India Globalization Capital has a 52 week low of $0.35 and a 52 week high of $4.71.
India Globalization Capital (NYSEAMERICAN:IGC) last posted its quarterly earnings results on Thursday, August 2nd. The construction company reported ($0.02) EPS for the quarter. India Globalization Capital had a negative net margin of 69.92% and a negative return on equity of 31.15%. The firm had revenue of $1.48 million for the quarter.
About India Globalization Capital
India Globalization Capital, Inc engages in the development and commercialization of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company operates through two segments, Legacy Infrastructure and Medical Cannabis Based Alternative Therapies.
Featured Article: Tariff
Receive News & Ratings for India Globalization Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for India Globalization Capital and related companies with MarketBeat.com's FREE daily email newsletter.